Butler University at AAPS 2026 PharmSci 360

Oct 25–28, 2026 New Orleans, LA ~4k attendees Website

Butler University brings 2 presentations to AAPS 2026 PharmSci 360 in New Orleans. Its program covers docetaxel nanoparticles that target both CD44 and αvβ3 to kill cancer cells more effectively, and how sunlight affects human health and what that means for regulation.

OrganizationAAPS 2026 PharmSci 360 Attendance
Butler University
Indianapolis, IN
butler.edu
Academic & healthcare
Private university in Indianapolis with a College of Pharmacy and Health Sciences.
Poster
Tue Oct 27
10:30am–11:30am
CD44/αvβ 3 Dual-Targeted Delivery of Docetaxel Using Hyaluronic Acid-Functionalized PLGA-PEG-NH 2 Nanoparticles and iRGD Enhances MDA-MB-231 Cytotoxicity
Solution Center · Poster T1030-01-04
Formulation and Delivery - Biomolecular
Talk
Wed Oct 28
1:30pm–2:30pm
Keynote: Potential Paradigm Shift in Basic Concepts of the Effects of Sunlight on Human Health and Its Regulatory Implications
207
Preclinical, Clinical, and Translational Sciences · with University of Illinois Chicago

Explore the full AAPS 2026 PharmSci 360 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full AAPS 2026 PharmSci 360 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Butler University

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American Association of Pharmaceutical Scientists (AAPS). Submit a correction